Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A re-assessment of the role of combined androgen blockade for advanced prostate cancer.

× No keyword cloud information.

20 in total

1. Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1.

Authors: Slawomir A Dutkiewicz
Journal: Int Urol Nephrol Date: 2011-09-20 Impact factor: 2.370

2. Proven efficacy of combined androgen depletion therapy.

Authors: Hideyuki Akaza
Journal: Curr Urol Rep Date: 2010-07 Impact factor: 3.092

3. Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study.

Authors: Yoichi Arai; Hideyuki Akaza; Takashi Deguchi; Masato Fujisawa; Mikio Hayashi; Yoshihiko Hirao; Hiroshi Kanetake; Seiji Naito; Mikio Namiki; Masaaki Tachibana; Michiyuki Usami; Yasuo Ohashi
Journal: J Cancer Res Clin Oncol Date: 2008-05-20 Impact factor: 4.553

Review 4. Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer.

Authors: Keri Wellington; Susan J Keam
Journal: Drugs Date: 2006 Impact factor: 9.546

5. Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer.

Authors: Keri Wellington; Susan J Keam
Journal: Drugs Aging Date: 2007 Impact factor: 3.923

6. Efficacy of maximal androgen blockade versus castration alone in the treatment of advanced prostate cancer: a retrospective clinical experience from a Chinese medical centre.

Authors: Xue-Qin Chen; Ying Huang; Xiang Li; Peng Zhang; Rui Huang; Juan Xia; Ni Chen; Qiang Wei; Yu-Chun Zhu; Yu-Ru Yang; Hao Zeng
Journal: Asian J Androl Date: 2010-08-09 Impact factor: 3.285

7. Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer.

Authors: Taeko Matsuoka; Koji Kawai; Tomokazu Kimura; Takahiro Kojima; Mizuki Onozawa; Jun Miyazaki; Hiroyuki Nishiyama; Shiro Hinotsu; Hideyuki Akaza
Journal: J Cancer Res Clin Oncol Date: 2014-10-18 Impact factor: 4.553

Review 8. Novel hormonal approaches in prostate cancer.

Authors: Terence W Friedlander; Charles J Ryan
Journal: Curr Oncol Rep Date: 2009-05 Impact factor: 5.075

Review 9. Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer.

Authors: Chih-Pin Chuu; John M Kokontis; Richard A Hiipakka; Junichi Fukuchi; Hui-Ping Lin; Ching-Yu Lin; Chiech Huo; Liang-Cheng Su
Journal: J Biomed Sci Date: 2011-08-23 Impact factor: 8.410

10. Maximal androgen blockade for the treatment of metastatic prostate cancer--a systematic review.

Authors: H Lukka; T Waldron; L Klotz; E Winquist; J Trachtenberg
Journal: Curr Oncol Date: 2006-06 Impact factor: 3.677